Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.
Graduate School of Peking Union Medical College, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Front Public Health. 2022 Aug 10;10:952899. doi: 10.3389/fpubh.2022.952899. eCollection 2022.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations are based on creatinine alone (CKD-EPIcr), cystatin C alone (CKD-EPIcys) and combined creatinine and cystatin C (CKD-EPIcr-cys). It remains unclear whether these equations perform differently in older adults with type 2 diabetes than they do in non-diabetic older individuals.
This single-center cross-sectional study was performed in adults aged ≥ 65 years between January 2019 and December 2021. Glomerular filtration rate (GFR) was measured by technetium-99m-diethylene triamine pentaacetic acid (Tc-DTPA) renal dynamic imaging. The bias (difference between measured and estimated GFR), precision [interquartile range (IQR) of the median difference between measured GFR and estimated GFR] and accuracy P30 (percentage of estimated GFR within 30% of measured GFR) were considered the criteria of equation performance.
Finally, 476 participants were enrolled, including 243 adults with type 2 diabetes and 233 non-diabetic adults. The mean age of the included participants was 71.69 ± 6.4 years and 262 (55%) were male. The mean measured GFR was 49.02 ± 22.45 ml/min/1.73 m. The CKD-EPIcr-cys equation showed significantly greater bias and lower accuracy (P30) in individuals with diabetes than in the non-diabetic group (median bias, 4.08 vs. 0.41 ml/min/1.73 m, respectively, < 0.05; P30, 63.78% vs. 78.54%, respectively, < 0.05). The precision IQR indicated that CKD-EPIcr-cys had also lower precision in individuals with diabetes than in the non-diabetic controls (17.27 vs. 15.49 ml/min/1.73 m, respectively). Similar results were observed for CKD-EPIcr and CKD-EPIcys equations. The P30 of all three equations failed to reach 80% in diabetic and non-diabetic groups.
The performance of the CKD-EPI equations was lower in a group of patients aged ≥ 65 years with type 2 diabetes than in non-diabetic counterparts. However, each equation still had limitations regarding accuracy in older adults with or without diabetes.
慢性肾脏病流行病学合作(CKD-EPI)方程基于肌酐(CKD-EPIcr)、胱抑素 C(CKD-EPIcys)或肌酐和胱抑素 C 的组合(CKD-EPIcr-cys)。目前尚不清楚这些方程在 2 型糖尿病老年患者中的表现是否与非糖尿病老年患者不同。
本单中心横断面研究于 2019 年 1 月至 2021 年 12 月期间在年龄≥65 岁的成年人中进行。肾小球滤过率(GFR)通过锝-99m-二乙三胺五乙酸(Tc-DTPA)肾动态成像测量。测量 GFR 和估计 GFR 之间的差异(测量 GFR 和估计 GFR 之间的中位数差异的四分位距[IQR])和准确性 P30(估计 GFR 在测量 GFR 的 30%范围内的百分比)被视为方程性能的标准。
最终纳入 476 名参与者,其中 243 名成年人患有 2 型糖尿病,233 名非糖尿病成年人。纳入参与者的平均年龄为 71.69±6.4 岁,262 名(55%)为男性。平均测量 GFR 为 49.02±22.45ml/min/1.73m。CKD-EPIcr-cys 方程在糖尿病患者中的偏差显著大于非糖尿病组(中位数偏差分别为 4.08 和 0.41ml/min/1.73m, 均<0.05;P30 分别为 63.78%和 78.54%,均<0.05),准确性 P30 也较低。IQR 表明,CKD-EPIcr-cys 在糖尿病患者中的精密度也低于非糖尿病对照组(分别为 17.27 和 15.49ml/min/1.73m)。CKD-EPIcr 和 CKD-EPIcys 方程也观察到类似的结果。所有三种方程在糖尿病和非糖尿病组中的 P30 均未达到 80%。
在年龄≥65 岁的 2 型糖尿病患者中,CKD-EPI 方程的性能低于非糖尿病患者。然而,在有或没有糖尿病的老年患者中,每种方程的准确性仍存在局限性。